- Service Details

Glatt can assist you in the formulation and process development to achieve an individual adaptation of the dissolution profile based on the specific drug. We offer fast drug release, modified & delayed release, targeted drug delivery and pulsatile drug re

- Service Details

Ascent offer end to end pharmaceutical formulation development services of Immediate Release tablets ranging from early phase development to clinical supplies for new chemical entities, generics and life cycle extension products.

- Service Details

Quotient offers formulation development services for solid oral dosage forms including Immediate, modified & sustained release tablets, multiparticulates, mini-tablets, granules, liquid filled capsules, Orally disintegrating tablets (ODTs) etc.

- Service Details

Athena has a broad range of drug delivery platforms. All these platforms are for oral drug delivery and are validated. We develop Orally Disintegrating Tablets (ODT) with customized drug release (SR, EC, Zero order and sublingual)

- Service Details

Biophore, is engaged in the development & manufacture of niche pharmaceutical products & modified oral solid dosage forms (Tablets, Capsules). It has emerged as a trusted partner in the generic industry across US, EU & other regulated markets.

- Service Details

Recro’s scientists are multi-particulate controlled release experts and innovators. We bring extensive experience in Wurster processing, rotor powder layering and rotary granulation for precision coating application and optimized solubility.

- Service Details

We offer end to end pharmaceutical formulation development services of Modified Release tablets ranging from early phase development to clinical supplies for new chemical entities, generics and life cycle extension products.

- Service Details

Quotient offers formulation development services for solid oral dosage forms including Immediate, modified & sustained release tablets, multiparticulates, mini-tablets, granules, liquid filled capsules, Orally disintegrating tablets (ODTs) etc.

- Service Details

Biophore, is engaged in the development & manufacture of niche pharmaceutical products & modified oral solid dosage forms (Tablets, Capsules). It has emerged as a trusted partner in the generic industry across US, EU & other regulated markets.

- Service Details

UPM has extensive experience and expertise in the development of solid oral dosage forms, including controlled and immediate release formulations (tablet/capsule).

- Service Details

Control the release rate by using Precision Particle Fabrication to produce exact, uniform microspheres. Active ingredients and matrix materials are first combined and then processed through the Orbis nozzle to create microspheres of the desired size and porosity.

- Service Details

We offer end to end pharmaceutical formulation development services of modified release capsules ranging from early phase development to clinical supplies for new chemical entities, generics and life cycle extension products.

- Service Details

Quotient Sciences has extensive experience in designing modified release formulations, from gastro-retention to sustained and pulsatile release formats.

- Service Details

Ropack Pharma Solutions offers formulation development expertise for products at all stages. From early-stage prototype development, formulation selection, formulation optimization and release profile definition to late-stage formulation troubleshooting and lifecycle management formulations.

- Service Details

Ropack Pharma Solutions offers formulation development expertise for products at all stages. From early-stage prototype development, formulation selection, formulation optimization and release profile definition to late-stage formulation troubleshooting and lifecycle management formulations.

- Service Details

Catalent is the most reliable brand of choice for all controlled release oral delivery solutions. With more than 15 years of experience launching over 50 products in all major markets, we continue to produce the most dosage-form solutions with superior qu

- Service Details

SUSHEN Medicamentos (SUSHEN), is a global company of end-to-end pharmaceutical services with focus on drug delivery research and product development. SUSHEN’s expertise can bring a complex formulation project in to clinical and bioequivalence with superior quality, innovative solution.

- Service Details

Custom’s expert chemists, scientists and process engineers — many with 35 years of experience in the pharmaceutical industry — offer an extensive range of clinical and product development expertise, including significant preformulation and formulation exp

- Service Details

Formulation Development is the core activity at Zenvision Pharma and it includes Pre-formulation studies, formulation development, analytical method development & validation, stability studies, Dossier preparation & Technology Transfer.

- Service Details

PSR team has extensive experience working with the following processes and delivery methods: Immediate/Modified/Extended Release Tablet/Capsule

- Service Details

Formulation Development is the core activity at Zenvision Pharma and it includes Pre-formulation studies, formulation development, analytical method development & validation, stability studies, Dossier preparation & Technology Transfer.

- Service Details

Pharmavize can manufacture various dosage forms including modified release products.

- Service Details

Chanelle Medical has thrived on the strength of our high quality science driven research and development programmes. There products are developed using our in-house expert scientists and with the assistance from our development laboratory in Amman, Jordan.

- Service Details

Orit Laboratories specializes in generic oral pharmaceutical development. Specifically, our focus is in analytical and formulation development of generic oral dosage forms for the US market.

- Service Details

Pharmathen is a research-oriented company aiming at the development of high quality pharmaceutical products both in the field of generics and innovative finished formulations. Pharmathen invests more than €20 million annually in Research and Development.